Piramal Pharma Solutions Press Releases

Press Releases

Coldstream to Attend Bio International Convention 2015

Posted on Fri, Jun 12, 2015 @ 05:04 PM by Jason Dwinell in lyophilized products, in aseptic filling, in antibody drug conjugates

Coldstream Laboratories, Inc., a Piramal Enterprises business, will be attending Bio Internatinal Convention 2015 in Philadelphia, PA. The event will take place at the Pennsylvania Convention Center June 15-18, 2015.

0 CommentsContinue Reading →

Coldstream to Exhibit at World ADC Conference

Posted on Thu, Oct 10, 2013 @ 09:40 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling, in antibody drug conjugates

Coldstream and Goodwin Biotechnology will co-exhibit at the World ADC Summit in San Francisco, CA, from October 14th to 17th.  Please meet us at Booth #13 to discuss your cytotoxic antibody drug conjugation needs.

0 CommentsContinue Reading →

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute

Posted on Mon, Sep 30, 2013 @ 03:15 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

LEXINGTON, KY--(Marketwired - Sep 24, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."

0 CommentsContinue Reading →

Coldstream to Attend Generics Conference

Posted on Tue, Jul 23, 2013 @ 06:17 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

Christopher A. Verbicky, Ph.D., MBA, will be attending the “6th Product and Pipeline Enhancement for Generics Conference” in this week in Washington, D.C.  The event will take place at the Sheraton Crystal City Hotel July 23 – 25, 2013.

0 CommentsContinue Reading →

Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates

Posted on Tue, Apr 30, 2013 @ 09:53 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling, in antibody drug conjugates

Plantation, Florida and Lexington, Kentucky-- Goodwin Biotechnology, Inc. (GBI) and Coldstream Laboratories, Inc. have established a collaboration for developing and manufacturing high-potency, highly cytotoxic materials (e.g., small molecules, protein toxins, cytotoxic antibody drug conjugates, and other bioconjugates).

0 CommentsContinue Reading →

Coldstream Partners with Local Company for Manufacture of New Equine Device

Posted on Mon, Apr 15, 2013 @ 10:46 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling

Photo Caption:  Equinext’s President and CEO, Eric Hauck, with Eric Smart, President and CEO of Coldstream Laboratories in Coldstream’s sterile manufacturing facility.

0 CommentsContinue Reading →

Mobile Isolators in Sterile Manufacturing

Posted on Fri, Sep 07, 2012 @ 05:11 PM by Kathy Sue Bennett in parenteral manufacturing, in isolator technology, in sterile manufacturing, in aseptic filling

The sterile manufacturing facility at Coldstream Laboratories employs unique mobile isolator technology to allow flexibility in executing a wide variety of manufacturing processes. Our isolators facilitate handling of difficult-to-manufacture drug products and ensure the safety of our workforce throughout the production process.  Mobile isolators provide an ISO Class 5 environment for aseptic processing and minimize human contact with the products we manufacture.   This technology allows Coldstream to process a variety of potent drug substances such as cytotoxins in an adaptable alternative manufacturing setting when compared to standard clean rooms.

0 CommentsContinue Reading →